Fund Holdings — Rosalind Advisors, Inc.

Total Portfolio Value:
$185.66M
Total Bought:
$66.28M
Total Sold:
$57.02M
Net Transaction:
+$9.26M
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Delcath Systems, Inc.(DCTH)2,650,3892,650,3890$21.20M$31.91M17.19%+$10.71M
Myomo, Inc.(MYO)3,021,3912,998,945-22,446$12.12M$19.31M10.40%+$7.20M
MediWound Ltd.SHS NEW(MDWD)628,050628,0500$11.34M$11.18M6.02%-$163.3K
Chimerix Inc03,050,000+3,050,000$0$10.61M5.72%+$10.61M
Xeris Biopharma Holdings Inc3,104,9953,104,9950$8.85M$10.53M5.67%+$1.68M
Abeona Therapeutics Inc.(ABEO)1,832,0001,805,390-26,610$11.58M$10.06M5.42%-$1.52M
Ocular Therapeutix, Inc.(OCUL)885,0001,128,700+243,700$7.70M$9.64M5.19%+$1.94M
UroGen Pharma Ltd.(URGN)0870,000+870,000$0$9.27M4.99%+$9.27M
Savara Inc.(SVRA)02,654,944+2,654,944$0$8.15M4.39%+$8.15M
Fennec Pharmaceuticals Inc.(FENC)01,259,876+1,259,876$0$7.96M4.29%+$7.96M
Cybin D/B/A Helus Pharma(HELP)0810,918+810,918$0$7.15M3.85%+$7.15M
Verona Pharma PlcADS275,000150,000-125,000$7.91M$6.97M3.75%-$945.8K
InspireMD, Inc.(NSPR)2,514,0462,495,783-18,263$6.74M$6.56M3.54%-$173.7K
Optinose Inc0876,996+876,996$0$5.86M3.16%+$5.86M
Profound Medical Corp.(PROF)485,973692,185+206,212$3.87M$5.20M2.80%+$1.33M
Verastem, Inc.(VSTM)0900,000+900,000$0$4.65M2.51%+$4.65M
Trevi Therapeutics, Inc.(TRVI)750,0001,062,500+312,500$2.50M$4.38M2.36%+$1.87M
Replimune Group, Inc.(REPL)0260,000+260,000$0$3.15M1.70%+$3.15M
PolyPid Ltd.(PYPD)679,1681,018,021+338,853$2.34M$3.09M1.67%+$758.4K
COMPASS Pathways plcADS(CMPS)781,423707,625-73,798$4.92M$2.67M1.44%-$2.25M
Kalvista Pharmaceuticals Inc303,864303,8640$3.52M$2.57M1.39%-$945.0K
Alpha Cognition Inc. Common Stock(ACOG)0252,753+252,753$0$1.49M0.80%+$1.49M
Filana Therapeutics, Inc.(FLNA)0417,400+417,400$0$985.1K0.53%+$985.1K
Biofrontera Inc.(BFRI)495,490811,918+316,428$659.0K$885.0K0.48%+$226.0K
Kiora Pharmaceuticals, Inc.(KPRX)0250,555+250,555$0$826.8K0.45%+$826.8K
Talphera, Inc.(TLPH)758,966613,939-145,027$650.1K$321.8K0.17%-$328.4K
Owlet, Inc.CL A(OWLT)270,00049,441-220,559$1.21M$220.0K0.12%-$992.3K
Relmada Therapeutics, Inc.(RLMD)0100,000+100,000$0$52.0K0.03%+$52.0K
ABIVAX Société AnonymeADS(ABVX)139,9830-139,983$1.61M$0—-$1.61M
Cellectar Biosciences, Inc.(CLRB)3,671,5500-3,671,550$7.86M$0—-$7.86M
Clearside Biomedical Inc127,2200-127,220$161.6K$0—-$161.6K
CorMedix Inc.(CRMD)1,475,0000-1,475,000$11.92M$0—-$11.92M
Cybin D/B/A Helus Pharma(HELP)1,075,1050-1,075,105$9.56M$0—-$9.56M
Fortress Biotech, Inc.(FBIO)502,8280-502,828$726.6K$0—-$726.6K
Journey Medical Corporation(DERM)105,9170-105,917$598.4K$0—-$598.4K
Kiora Pharmaceuticals Inc255,5550-255,555$935.3K$0—-$935.3K
Newamsterdam Pharma Co Nv
ORDINARY SHARES
10,1230-10,123$168.0K$0—-$168.0K
Optinose Inc8,287,5030-8,287,503$5.55M$0—-$5.55M
Outlook Therapeutics, Inc.(OTLK)450,0000-450,000$2.40M$0—-$2.40M
Veru Inc.(VERU)2,694,5030-2,694,503$2.07M$0—-$2.07M
Vor Biopharma Inc.(VOR)76,6850-76,685$53.7K$0—-$53.7K
Page 1 of 1
Rosalind Advisors, Inc. — 13F Holdings — Q4 2024 | TickerTrail